Digital-first heart failure care in Uganda
ImpleMEntation of a Digital-first care deLiverY model for heart failure in Uganda (MEDLY Uganda)
This program uses a phone-based system to help people with heart failure in Uganda manage their symptoms and daily care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11406813 on NIH RePORTER |
What this research studies
You would use a phone-based program called Medly Uganda that gives symptom checks, reminders, and ways to connect with clinic staff. The team will roll this out at six regional referral hospital outpatient clinics across Uganda and teach patients and providers how to use it. Researchers will follow people using surveys, interviews, and medical records to see how well the program is used and whether health and hospital visits change. The project prioritizes reaching patients from different regions and socioeconomic backgrounds so the results apply broadly.
Who could benefit from this research
Good fit: Adults diagnosed with heart failure who receive outpatient care at one of the participating Ugandan regional referral hospitals and who can use or access a mobile phone are ideal candidates.
Not a fit: People without reliable access to a mobile phone, those with severe cognitive impairment, or patients who are only hospitalized and not followed in the participating outpatient clinics may not benefit from this program.
Why it matters
Potential benefit: If successful, this could help people with heart failure feel better, manage symptoms earlier, and reduce hospital visits in Uganda.
How similar studies have performed: Phone- and app-based self-care programs have improved symptoms and reduced readmissions in higher-income countries, but this digital approach is less tested in sub-Saharan Africa and is relatively novel there.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Schwartz, Jeremy Ian — Yale University
- Study coordinator: Schwartz, Jeremy Ian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.